Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.
INTRODUCTION: Treatment for osteoporosis commonly includes the use of bisphosphonates. Serious side effects of these drugs are caused by the inhibition of bone resorption as a result of osteoclast apoptosis. Treatment using calcitonin along with bisphosphonates overcomes these side-effects in some p...
Main Authors: | Yi-Jie Kuo, Fon-Yih Tsuang, Jui-Sheng Sun, Chi-Hung Lin, Chia-Hsien Chen, Jia-Ying Li, Yi-Chian Huang, Wei-Yu Chen, Chin-Bin Yeh, Jia-Fwu Shyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3391248?pdf=render |
Similar Items
-
Calcitonin Increases the Activity of ERK and Bcl-2 in Osteoclasts and Reduces SDCP-induced Osteoclasts Apoptosis
by: Yi-Chein Huang, et al.
Published: (2010) -
Calcitonin reduces SDCP-induced osteoclast apoptosis and increases its efficacy to treat osteopenic rat
by: Chen, Weiyu, et al.
Published: (2011) -
Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats
by: Chen-Yuan Hsiao, et al.
Published: (2020-09-01) -
The Effects of Sintered Dicalcium Pyrophosphate (SDCP) on Osteoporotic Treatment and Osteoporotic Fracture Healing
by: Yi-Jie Kuo, et al.
Published: (2014) -
Study of calcitonin-induced survival pathways in osteoclasts
by: Chia-Yin Li, et al.
Published: (2008)